Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)

Market Cap	5.03B +24.3%
Revenue (ttm)	1.68B -4.5%
Net Income	295.36M +8.2%
EPS	0.67 +10.7%
Shares Out	439.08M
PE Ratio	17.09
Forward PE	16.47
Dividend	0.25 (2.10%)
Ex-Dividend Date	Jan 16, 2026

Volume	7,629,400
Average Volume	6,059,167
Open	11.53
Previous Close	11.45
Day's Range	11.19 - 11.61
52-Week Range	8.47 - 13.50
Beta	0.35
RSI	36.96
Earnings Date	Apr 25, 2026

About SHA:603998

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, gynecological drugs, and anti-infective drugs. The company's main products include Xuesetong dispersible tablets, Xuesetong tablets, Garcinia bone-strengthening tablets, Dieda Huoxue ca...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 1,807
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603998

Financial Performance

In 2024, SHA:603998's revenue was 1.78 billion, an increase of 9.15% compared to the previous year's 1.63 billion. Earnings were 255.22 million, an increase of 36.61%.